CD20 Immunophenotyping by Flow Cytometry Test
Comprehensive Introduction to CD20 Immunophenotyping
Immunophenotyping by Flow Cytometry CD20 Test represents a cutting-edge diagnostic approach in modern hematology and oncology. This sophisticated laboratory technique provides crucial insights into B-cell malignancies by detecting the presence and density of CD20 surface antigens on immune cells. As a pivotal marker in lymphocyte characterization, CD20 plays an essential role in identifying various hematological disorders and guiding targeted therapeutic interventions.
The importance of this test extends beyond mere diagnosis; it serves as a cornerstone for treatment selection, particularly for monoclonal antibody therapies like Rituximab that specifically target CD20-positive cells. By providing precise cellular profiling, this test enables healthcare providers to develop personalized treatment strategies and monitor therapeutic responses with unprecedented accuracy.
What the CD20 Test Measures and Detects
The Immunophenotyping by Flow Cytometry CD20 Test specifically measures:
- CD20 antigen expression levels on B-cell surfaces
- Percentage of CD20-positive cells in blood or bone marrow samples
- B-cell population characteristics and distribution patterns
- Abnormal B-cell clones indicative of malignant transformation
- Response markers for CD20-targeted immunotherapy
This advanced diagnostic tool detects various B-cell malignancies including non-Hodgkin lymphoma, chronic lymphocytic leukemia, and other lymphoproliferative disorders. The test’s precision allows for distinguishing between reactive and neoplastic B-cell populations, providing critical diagnostic clarity.
Who Should Consider CD20 Immunophenotyping Testing
This specialized test is recommended for individuals experiencing:
- Unexplained lymph node enlargement or swelling
- Persistent fatigue and general weakness
- Night sweats and unexplained fever episodes
- Unexplained weight loss exceeding 10% of body weight
- Recurrent infections or abnormal bleeding tendencies
- Abnormal complete blood count results
- Suspected B-cell lymphoma or leukemia
- Monitoring treatment response in CD20-positive malignancies
Significant Benefits of CD20 Testing
Undergoing CD20 Immunophenotyping provides multiple clinical advantages:
- Early Cancer Detection: Identifies B-cell malignancies at initial stages for timely intervention
- Precise Diagnosis: Differentiates between various lymphoma subtypes with high accuracy
- Treatment Guidance: Determines eligibility for CD20-targeted therapies
- Response Monitoring: Tracks treatment effectiveness and disease progression
- Prognostic Information: Provides valuable insights into disease course and outcomes
- Minimal Sample Requirement: Requires only small blood or bone marrow samples
Understanding Your Test Results
Your CD20 Immunophenotyping results will be interpreted by experienced hematologists and oncologists:
- Normal Results: Indicate typical CD20 expression patterns consistent with healthy B-cell populations
- Elevated CD20: May suggest B-cell lymphoma or other proliferative disorders requiring further evaluation
- Abnormal Patterns: Could indicate specific lymphoma subtypes or treatment-resistant disease
- Quantitative Analysis: Provides precise percentages of CD20-positive cells for treatment planning
Our specialists will provide comprehensive explanations of your results and recommend appropriate next steps based on the findings. All reports include detailed interpretations and clinical recommendations.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $88 |
| Regular Price | $112 |
Turnaround Time and Sample Requirements
Sample Collection: Daily by 9 AM
Report Delivery: Same Day Results
Sample Type: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube AND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube.
Shipping Instructions: Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form.
Nationwide Testing Availability
We have comprehensive testing facilities across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.
Book Your CD20 Immunophenotyping Test Today
Take the first step toward accurate diagnosis and effective treatment planning. Our experienced team of hematologists and flow cytometry specialists are ready to provide you with comprehensive testing and personalized care.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your appointment or discuss your testing needs with our medical professionals.
Early detection through advanced immunophenotyping can significantly improve treatment outcomes and quality of life. Trust General Genetics Corporation for precise, reliable CD20 testing with same-day results and expert interpretation.
